verified SJR 0,271 · Q3 • database Scopus / SJR & Web of Science & DOAJ indexed

Italy · Page Press Publications

workspace_premium Q3 — Oncology visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Rare Tumors

Rare Tumors is a journal indexed in SJR in Oncology and Histology with an H index of 22. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 805,5 €. The scope of the journal is focused on rare cancers, haematological malignancies, rare tumours. It has an SJR impact factor of 0,271 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,271.

ISSN: 2036-3605

Publisher: Page Press Publications

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,271 Q3

H-index 22

Acceptance rate pie_chart

43%

Source Acceptance_Rate

Time to publication hourglass_top

15 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

806 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,271

H-index

Docs (year)

Docs 3y

Total refs

538

Cites 3y

Citable 3y

Cites/Doc 2y

0.68

Ref/Doc

19.21

Immediate OA

805,5 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Lingual metastasis from renal cell carcinoma: a case report and literature review

Two cases of retrobulbar meningioma excised by skull base approaches

This is the full PDF of Rare Tumors 2009, volume 1, issue 1.

The importance of patient reported functional outcome in paediatric desmoid fibromatosis

Solitary fibrous tumor

Sclerosing angiomatoid nodular transformation of the spleen masquerading as a sarcoma metastasis

Retrorectal epidermoid cyst with unusually elevated serum SCC level, initially diagnosed as an ovarian tumor

Progression of choroidal metastasis of ovarian serous cystoadenocarcinoma after intravitreal bevacizumab treatment

Perivascular epithelioid cell neoplasm of the uterine cervix: an unusual tumor in an unusual location

Peri-ampullary mixed acinar-endocrine carcinoma

NORD Funding Available for Pseudomyxoma Peritonei Seed Grants, 2010

Multiple urinary bladder masses from metastatic prostate adenocarcinoma

SHOW MORE ARTICLES

Metastatic rectal cancer to the breast

Merkel cell carcinoma of skin -current controversies and recommendations

Localized nasal cavity, sinus, and massive bilateral orbital involvement by human T cell leukemia virus 1 adult T cell lymphoma, with epidermal hypertrophy due to mite infestation

Local control of extra-abdominal desmoid tumors: systematic review and meta-analysis

A case of nephrotic syndrome associated with hydatiform mole

Large cell neuroendocrine carcinoma originating from the uterine endometrium: a report on magnetic resonance features of 2 cases with very rare and aggressive tumor

Granular cell tumour of the urinary bladder

Giant Brunner's gland adenoma

Fertility-sparing operation for recurrence of uterine cervical perivascular epithelioid cell tumor

Familial adenomatous polyposis with synchronous invasive colonic carcinomas and metastatic jejunal adenocarcinoma in a Nigerian male

Endometrial stromal sarcoma with selective polyvinyl alcohol embolization of a pulmonary metastasis after recurrent hemoptysis and expansive growth

Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents

FAQs

Rare Tumors has an SJR of 0,271 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is 805,5 EUR.

The acceptance rate recorded for Rare Tumors is 43%.

Rare Tumors

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Rare Tumors?

What is the APC / publication cost?

What is the acceptance rate?